Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients?

doi:10.5500/wjt.v10.i11.297

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6911)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

508

WORD

271

HTML

2684

Figures (1-2)

336

Tables (1-1)

304

Sum=4103

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

345

Download

652

Sum=997

Publishing Process of This Article

Item

Count

Browse

650

Download

1161

Sum=1811

Nov 28, 2020 (publication date) through Nov 16, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Opinion Review

World J Transplant. Nov 28, 2020; 10(11): 297-306
Published online Nov 28, 2020. doi: 10.5500/wjt.v10.i11.297

Full Size Figure Download Figure

Figure 1 Metastatic site of hepatocellular recurrence after liver transplantation in a patient who received lenvatinib.

Citation: Piñero F, Thompson M, Marín JI, Silva M. Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients? World J Transplant 2020; 10(11): 297-306
URL: https://www.wjgnet.com/2220-3230/full/v10/i11/297.htm
DOI: https://dx.doi.org/10.5500/wjt.v10.i11.297